Advinus optimistic about diabetes drug candidate

05/4/2009 | Business Standard (India)

Advinus Therapeutics plans to begin in June clinical trials of an experimental molecule that could be categorized under a new class of diabetes drugs, CEO Rashmi Barbhaiya said. The compound is being developed in Advinus' facility in Pune, India, which handles seven to eight drug-discovery programs.

View Full Article in:

Business Standard (India)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Assistant General Counsel
Cardinal Health
Columbus, OH
Regulatory Affairs Specialist
Stryker
Mahwah, NJ
Sr. Principal OptoMechanical Engineer - 14000008M2
Abbott
San Jose, CA
Senior Director Medical Affairs
Edwards Lifesciences
Irvine, CA
Sr. Principal Electrical Engineer - 14000008LR
Abbott
San Jose, CA